SCHEMBL1245079

SCHEMBL1245079

CCCCCCCCCC/C=C/CO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.58
TRPV1 Q8NER1 1/20 0.58
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
TOP1 P11387 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20178791 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL294780 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2971122 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL8912032 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2971125 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2974048 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL3491409 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1265793 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5519456 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL295522 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3528776-B1 REDUCED-ETHANOL MOUTH RINSE FORMULATIONS KENVUE BRANDS LLC (US) 2025-11-26 EP claimed
US-20240298681-A1 METHODS AND COMPOSITIONS FOR AFFECTING THE FLAVOR AND AROMA PROFILE OF CONSUMABLES IMPOSSIBLE FOODS INC. 2024-09-12 US claimed
CN-117756752-A Prodrug anti-tumor preparation for improving safety of paclitaxel and application thereof 沈阳药科大学 2024-03-26 CN claimed
US-20230125249-A1 USE OF VOLATILE COMPOUNDS TO MODULATE THE PERCEPTION OF MUSK FIRMENICH SA (CH) 2023-04-27 US claimed
CN-115715190-A Redeciclovir and Redeciclovir analogs, solutions and nanoparticle, liposome and microparticle compositions for treating viral infections 密歇根大学董事会 2023-02-24 CN claimed
CN-114732052-A Methods and compositions for affecting flavor and odor characteristics of consumer products 非凡食品有限公司 2022-07-12 CN claimed
US-11224241-B2 Methods and compositions for affecting the flavor and aroma profile of consumables IMPOSSIBLE FOODS INC. (US) 2022-01-18 US claimed
US-11219232-B2 Methods and compositions for affecting the flavor and aroma profile of consumables IMPOSSIBLE FOODS INC. (US) 2022-01-11 US claimed
US-11013250-B2 Methods and compositions for consumables IMPOSSIBLE FOODS INC. (US) 2021-05-25 US claimed
US-10993462-B2 Methods and compositions for consumables IMPOSSIBLE FOODS INC. (US) 2021-05-04 US claimed
US-10314325-B2 Methods and compositions for affecting the flavor and aroma profile of consumables IMPOSSIBLE FOODS INC. (US) 2019-06-11 US claimed
US-20190116855-A1 METHODS AND COMPOSITIONS FOR CONSUMABLES IMPOSSIBLE FOODS INC. 2019-04-25 US claimed
WO-2019010263-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2019-01-10 WO claimed
WO-2019010265-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2019-01-10 WO claimed
US-20190010293-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2019-01-10 US claimed
US-20190010427-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2019-01-10 US claimed
US-8592621-B2 Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease SYMRISE AG (DE) 2013-11-26 US claimed
US-20110045069-A1 PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE SYMRISE GMBH CO. KG (DE) 2011-02-24 US claimed
EP-1082287-B1 SLOW RELEASE OF FRAGRANT COMPOUNDS IN PERFUMERY USING 2-BENZOYL BENZOATES, 2-ALKANOYL BENZOATES OR ALPHA-KETO ESTERS FIRMENICH & CIE (CH) 2004-03-17 EP claimed
US-6369026-B1 FOR USE IN PERFUME OR A COLOGNE, A BATH OR SHOWER GEL, A SHAMPOO, A HAIR SPRAY OR OTHER HAIR-CARE PRODUCT, A COSMETIC PREPARATION, A BODY DEODORANT, A SOLID OR LIQUID AIR-FRESHENER, A DETERGENT OR A FABRIC SOFTENER FIRMENICH SA (CH) 2002-04-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230125249-A1 USE OF VOLATILE COMPOUNDS TO MODULATE THE PERCEPTION OF MUSK TRPA1, TRPM5, TRPM8 FAAH 54/4885TRPV1 12/4885TERT 4875/4885
US-20110045069-A1 PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE TAS1R2, TAS2R5, TAS2R1 FAAH 2277/4885TRPV1 116/4885TERT 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.